Breast cancer remains the leading cause of death among women globally, with 2.2 million cases reported in 2020 alone. Early detection through regular mammography screenings has proven to be effective in reducing mortality rates. As the World Health Organization (WHO) strives to achieve a 2.5% annual reduction in breast cancer deaths and prevent 25% of deaths by 2030, the success of screening programs becomes paramount. Unfortunately, adherence to these programs falls short of expectations within certain population groups, emphasizing the urgent need for targeted interventions.
“Dissemination of breast cancer–screening programs is still lacking in most of the vulnerable populations,” says Fátima Morales, Affiliate Assistant Professor at the Sbarro Health Research Organization (SHRO) at Temple University. “But, we observed important favorable changes in those cases in which the population undergoes health education sessions, they are informed about cancer-screening programs, or they seek medical attention.”
The research was conducted by Morales in collaboration with coauthors including Dr. Palmira Immordino, Professor at the University of Palermo, Italy, and Dr. Antonio Giordano, Founder and President of SHRO.
“Particularly concerning is the lowest adherence among women who are Black, Asian, Hispanic, and immigrants,” Morales says.
Awareness programs aimed at migrant and nonwhite women, utilizing familiar settings such as schools, media outlets, and supermarkets, as well as education programs have shown promise in increasing knowledge and participation.
“By emphasizing the importance of breast cancer screening and fostering a sense of empowerment,” says Giordano, “these campaigns can effectively increase participation rates.”
Addressing the identified barriers will not only contribute to reducing breast cancer mortality rates but also ensure equitable access to life-saving screenings for all women.
About the Sbarro Health Research Organization (SHRO)
The Sbarro Health Research Organization is a non-profit charity committed to funding excellence in basic genetic research to cure and diagnose cancer, cardiovascular diseases, diabetes and related chronic illnesses and to foster the training of young doctors in a spirit of professionalism and humanism (www.shro.org)